Logo image of CLI.MI

CENTRALE DEL LATTE D'ITALIA (CLI.MI) Stock Fundamental Analysis

Europe - BIT:CLI - IT0003023980 - Common Stock

3.7 EUR
0 (0%)
Last: 9/11/2025, 7:00:00 PM
Fundamental Rating

5

CLI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 59 industry peers in the Food Products industry. While CLI is still in line with the averages on profitability rating, there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on CLI.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CLI was profitable.
CLI had a positive operating cash flow in the past year.
Each year in the past 5 years CLI has been profitable.
Each year in the past 5 years CLI had a positive operating cash flow.
CLI.MI Yearly Net Income VS EBIT VS OCF VS FCFCLI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.80%, CLI is in line with its industry, outperforming 54.24% of the companies in the same industry.
CLI has a Return On Equity of 14.22%. This is in the better half of the industry: CLI outperforms 76.27% of its industry peers.
CLI has a better Return On Invested Capital (11.61%) than 88.14% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CLI is below the industry average of 7.03%.
The last Return On Invested Capital (11.61%) for CLI is above the 3 year average (4.02%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.8%
ROE 14.22%
ROIC 11.61%
ROA(3y)0.98%
ROA(5y)1.12%
ROE(3y)3.7%
ROE(5y)4.3%
ROIC(3y)4.02%
ROIC(5y)3.66%
CLI.MI Yearly ROA, ROE, ROICCLI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

CLI has a Profit Margin (1.88%) which is in line with its industry peers.
In the last couple of years the Profit Margin of CLI has grown nicely.
With a Operating Margin value of 3.71%, CLI perfoms like the industry average, outperforming 42.37% of the companies in the same industry.
In the last couple of years the Operating Margin of CLI has grown nicely.
CLI has a Gross Margin of 19.29%. This is in the lower half of the industry: CLI underperforms 79.66% of its industry peers.
In the last couple of years the Gross Margin of CLI has declined.
Industry RankSector Rank
OM 3.71%
PM (TTM) 1.88%
GM 19.29%
OM growth 3Y15.43%
OM growth 5YN/A
PM growth 3Y16.01%
PM growth 5YN/A
GM growth 3Y-0.63%
GM growth 5Y-14.6%
CLI.MI Yearly Profit, Operating, Gross MarginsCLI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CLI is creating value.
CLI has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CLI remains at a similar level compared to 5 years ago.
The debt/assets ratio for CLI is higher compared to a year ago.
CLI.MI Yearly Shares OutstandingCLI.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CLI.MI Yearly Total Debt VS Total AssetsCLI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

CLI has an Altman-Z score of 2.55. This is not the best score and indicates that CLI is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.55, CLI is in the better half of the industry, outperforming 62.71% of the companies in the same industry.
The Debt to FCF ratio of CLI is 6.36, which is on the high side as it means it would take CLI, 6.36 years of fcf income to pay off all of its debts.
CLI has a Debt to FCF ratio (6.36) which is comparable to the rest of the industry.
CLI has a Debt/Equity ratio of 0.56. This is a neutral value indicating CLI is somewhat dependend on debt financing.
The Debt to Equity ratio of CLI (0.56) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 6.36
Altman-Z 2.55
ROIC/WACC2.38
WACC4.88%
CLI.MI Yearly LT Debt VS Equity VS FCFCLI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

CLI has a Current Ratio of 0.86. This is a bad value and indicates that CLI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.86, CLI is not doing good in the industry: 77.97% of the companies in the same industry are doing better.
A Quick Ratio of 0.69 indicates that CLI may have some problems paying its short term obligations.
The Quick ratio of CLI (0.69) is worse than 62.71% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.69
CLI.MI Yearly Current Assets VS Current LiabilitesCLI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

6

3. Growth

3.1 Past

CLI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.57%, which is quite impressive.
Measured over the past years, CLI shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.63% on average per year.
CLI shows a small growth in Revenue. In the last year, the Revenue has grown by 3.88%.
CLI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.83% yearly.
EPS 1Y (TTM)36.57%
EPS 3Y24.63%
EPS 5YN/A
EPS Q2Q%25.9%
Revenue 1Y (TTM)3.88%
Revenue growth 3Y7.26%
Revenue growth 5Y14.83%
Sales Q2Q%-4.76%

3.2 Future

CLI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.31% yearly.
The Revenue is expected to grow by 3.36% on average over the next years.
EPS Next Y-2.22%
EPS Next 2Y15.47%
EPS Next 3Y15.31%
EPS Next 5YN/A
Revenue Next Year8.24%
Revenue Next 2Y4.56%
Revenue Next 3Y3.36%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLI.MI Yearly Revenue VS EstimatesCLI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
CLI.MI Yearly EPS VS EstimatesCLI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6 0.8

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.07, the valuation of CLI can be described as very cheap.
Based on the Price/Earnings ratio, CLI is valued cheaper than 94.92% of the companies in the same industry.
CLI is valuated cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 6.11, the valuation of CLI can be described as very cheap.
CLI's Price/Forward Earnings ratio is rather cheap when compared to the industry. CLI is cheaper than 94.92% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CLI to the average of the S&P500 Index (22.73), we can say CLI is valued rather cheaply.
Industry RankSector Rank
PE 5.07
Fwd PE 6.11
CLI.MI Price Earnings VS Forward Price EarningsCLI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLI is valued cheaply inside the industry as 98.31% of the companies are valued more expensively.
96.61% of the companies in the same industry are more expensive than CLI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.96
EV/EBITDA 2.51
CLI.MI Per share dataCLI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The decent profitability rating of CLI may justify a higher PE ratio.
A more expensive valuation may be justified as CLI's earnings are expected to grow with 15.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.47%
EPS Next 3Y15.31%

0

5. Dividend

5.1 Amount

No dividends for CLI!.
Industry RankSector Rank
Dividend Yield N/A

CENTRALE DEL LATTE D'ITALIA

BIT:CLI (9/11/2025, 7:00:00 PM)

3.7

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.01%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap51.80M
Analysts80
Price Target5.81 (57.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 5.07
Fwd PE 6.11
P/S 0.1
P/FCF 3.96
P/OCF 3.15
P/B 0.75
P/tB 1.05
EV/EBITDA 2.51
EPS(TTM)0.73
EY19.73%
EPS(NY)0.61
Fwd EY16.38%
FCF(TTM)0.93
FCFY25.26%
OCF(TTM)1.17
OCFY31.7%
SpS37.15
BVpS4.92
TBVpS3.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.8%
ROE 14.22%
ROCE 16.47%
ROIC 11.61%
ROICexc 18.89%
ROICexgc 25.91%
OM 3.71%
PM (TTM) 1.88%
GM 19.29%
FCFM 2.52%
ROA(3y)0.98%
ROA(5y)1.12%
ROE(3y)3.7%
ROE(5y)4.3%
ROIC(3y)4.02%
ROIC(5y)3.66%
ROICexc(3y)6.06%
ROICexc(5y)5.59%
ROICexgc(3y)8.01%
ROICexgc(5y)7.3%
ROCE(3y)5.7%
ROCE(5y)5.19%
ROICexcg growth 3Y32.21%
ROICexcg growth 5YN/A
ROICexc growth 3Y30.06%
ROICexc growth 5YN/A
OM growth 3Y15.43%
OM growth 5YN/A
PM growth 3Y16.01%
PM growth 5YN/A
GM growth 3Y-0.63%
GM growth 5Y-14.6%
F-Score7
Asset Turnover2.02
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 6.36
Debt/EBITDA 1.11
Cap/Depr 21.57%
Cap/Sales 0.64%
Interest Coverage 5.89
Cash Conversion 47.24%
Profit Quality 133.55%
Current Ratio 0.86
Quick Ratio 0.69
Altman-Z 2.55
F-Score7
WACC4.88%
ROIC/WACC2.38
Cap/Depr(3y)17.55%
Cap/Depr(5y)36.42%
Cap/Sales(3y)0.86%
Cap/Sales(5y)2.07%
Profit Quality(3y)1366.96%
Profit Quality(5y)1110.01%
High Growth Momentum
Growth
EPS 1Y (TTM)36.57%
EPS 3Y24.63%
EPS 5YN/A
EPS Q2Q%25.9%
EPS Next Y-2.22%
EPS Next 2Y15.47%
EPS Next 3Y15.31%
EPS Next 5YN/A
Revenue 1Y (TTM)3.88%
Revenue growth 3Y7.26%
Revenue growth 5Y14.83%
Sales Q2Q%-4.76%
Revenue Next Year8.24%
Revenue Next 2Y4.56%
Revenue Next 3Y3.36%
Revenue Next 5YN/A
EBIT growth 1Y17.84%
EBIT growth 3Y23.81%
EBIT growth 5YN/A
EBIT Next Year133.78%
EBIT Next 3Y38.93%
EBIT Next 5YN/A
FCF growth 1Y-62.61%
FCF growth 3Y-17.37%
FCF growth 5YN/A
OCF growth 1Y-55.87%
OCF growth 3Y-18.49%
OCF growth 5Y10.4%